AtriCure, Inc. (ATRC) — Analyst outlook / Analyst consensus target is. Based on 19 analyst ratings, the consensus is bullish — 18 Buy, 1 Hold.
The consensus price target is $50.67 (low: $44.00, high: $55.00), representing an upside of 72.3% from the current price $29.40.
Analysts estimate Earnings Per Share (EPS) of $-0.82 and revenue of $0.46B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.95 vs est $-0.82 (missed -16.4%). 2025: actual $-0.24 vs est $-0.36 (beat +34%). Analyst accuracy: 67%.
ATRC Stock — 12-Month Price Forecast
$50.67
▲ +72.35% Upside
Average Price Target
Based on 19 Wall Street analysts offering 12-month price targets for AtriCure, Inc., the average price target is $50.67, with a high forecast of $55.00, and a low forecast of $44.00.
The average price target represents a +72.35% change from the last price of $29.40.
Highest Price Target
$55.00
Average Price Target
$50.67
Lowest Price Target
$44.00
ATRC Analyst Ratings
Buy
Based on 19 analysts giving stock ratings to AtriCure, Inc. in the past 3 months
EPS Estimates — ATRC
67%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual –$0.95
vs Est –$0.82
▼ 14.1% off
2025
Actual –$0.24
vs Est –$0.36
▲ 51.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — ATRC
100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.465B
vs Est $0.462B
▲ 0.7% off
2025
Actual $0.535B
vs Est $0.534B
▲ 0.1% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
